Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. ESMO Videos
  3. Gastrointestinal Cancer Videos

Advances in Targeted Agents for Rare Molecular Subgroups in Colon Cancer

Insights in Gastrointestinal Cancers

Login to get immediate access to this content.

Login

Chair: Julien Taieb, France
Discussants: 

  • Maria Elena Elez Fernandez, Spain
  • Dominik Modest, Germany

In this Insights video, the panel discuss the evolving treatment landscape for colorectal cancer, covering patients with BRAF mutations and recent therapy changes. They highlight emerging therapies to overcome resistance, challenges with KRAS mutations, and the significance of HER2 amplification as a biomarker. The potential of immunotherapy for MSI-high patients is explored, along with updates on neoadjuvant therapy and the complexities of patient journeys. Insights into future treatments and ongoing clinical trials are also shared.

Related Videos

Screenshot Christelle DE LA FOUCHARDIERE
Screenshot Peter DE GOOYER
Screenshot Salvatore SIENA
Screenshot Yelena JANJIGIAN

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.